Insider Transactions in Q3 2025 at Silverback Therapeutics, Inc. (SBTX)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 01
2025
|
Eric Karas Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
15,000
-59.25%
|
$240,000
$16.99 P/Share
|
|
Jul 01
2025
|
Eric Karas Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+37.21%
|
$15,000
$1.5 P/Share
|